Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers-Reference-Cited by-同舟云学术

Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers

Published:2017-07-10 Issue:44 Volume:36 Page:6143-6153
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Liu Y,Cheng Y,Xu Y,Wang Z,Du X,Li C,Peng J,Gao L,Liang X,Ma C

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2017209.pdf

Reference48 articles.

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A . Global cancer statistics, 2012. CA Cancer J Clin 2015; 65: 87–108.

2. Giannelli G, Rani B, Dituri F, Cao Y, Palasciano G . Moving towards personalised therapy in patients with hepatocellular carcinoma: the role of the microenvironment. Gut 2014; 63: 1668–1676.

3. Ferrone C, Dranoff G . Dual roles for immunity in gastrointestinal cancers. J Clin Oncol 2010; 28: 4045–4051.

4. Lin EW, Karakasheva TA, Hicks PD, Bass AJ, Rustgi AK . The tumor microenvironment in esophageal cancer. Oncogene 2016; 35: 5337–5349.

5. Zhang L, Song X, Mohri Y, Qiao L . Role of inflammation and tumor microenvironment in the development of gastrointestinal cancers: what induced pluripotent stem cells can do? Curr Stem Cell Res Ther 2015; 10: 245–250.

Cited by 273 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NK cell-based immunotherapy in hepatocellular carcinoma: An attractive therapeutic option for the next decade;Cellular Signalling;2024-12

2. CT-based radiomics nomogram to predict proliferative hepatocellular carcinoma and explore the tumor microenvironment;Journal of Translational Medicine;2024-09-02

3. A novel signature constructed by cuproptosis-related RNA methylation regulators suggesting downregulation of YTHDC2 may induce cuproptosis resistance in colorectal cancer;International Immunopharmacology;2024-09

4. Reprogramming natural killer cells for cancer therapy;Molecular Therapy;2024-09

5. New perspectives on chemokines in hepatocellular carcinoma therapy: a critical pathway for natural products regulation of the tumor microenvironment;Frontiers in Immunology;2024-08-14